Research principles for studies that aim to estimate the cost of reaching zero-dose children. This document is the result of a consultative process that involved the Gavi Secretariat, WHO, UNICEF, the Bill & Melinda Gates Foundation, ThinkWell, CDC, JSI, VillageReach, PATH, Boston University, Swiss Tropical and Public Health Institute, Levin & Morgan LLC, and the University of Montreal [2024].
Methods for quantifying the equity impacts of health programs in high, middle, and low-income countries. The methods can be tailored to analyze different equity concerns in different decision-making contexts [University of York, 2020].
Publication which gives a standardized approach for measuring multivariate equity in vaccine coverage, economic impact, and health outcomes [VERSE project, 2022].
This toolkit enables users to compare the level of vaccine coverage against the level of equity in a country and quantify the influence of key sociodemographic factors to inequity [VERSE project, 2022].
This Guide presents a standardized approach for evaluating the incremental costs of ZDLA interventions. It was developed for use by the ZDLA country teams who had limited prior experience with cost analysis. It is not meant to be fully exhaustive of costing methodologies but to complement other standardized methods available.
If you have any suggestions of further guidance documents or tools for this page, please send them to immunization_economics@kemri-wellcome.org.
For many years, the Immunization Economics Community of Practice has supported researchers, policymakers, and practitioners around the world to use economic evidence to make better immunization decisions so that limited resources can save more lives.
Our work has been generously supported by the Gates Foundation and Gavi, the Vaccine Alliance, but our current funding ends this year. We are now seeking donations to help us bridge this transition and keep the community alive.
Donate